$0.9752
-0.0798-7.56%
At close: Nov 13, 4:00 PM EST
$0.9400
-0.0352-3.61%
After Hours: 5:29 PM EST
Decoy Therapeutics Inc
DCOYNASDAQ
Decoy Therapeutics fell 92.7% from $14.52 to $1.06, behind the S&P 500's +12.3%. Its worst day was Jan 14 (−30.4%), and its low came Oct 26 at $0.91.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Decoy Therapeutics shares fell 23.4%, while the S&P 500 fell 0.9%.
−23.4% · S&P 500 −0.9%
Decoy Therapeutics closed at its highest level of the year, 3.3% above where the year started.
+53.4% · S&P 500 −0.2%
Story events cover the past 12 months · Times ET
Decoy Therapeutics shares rose 25.8%, while the S&P 500 rose 1.9%.
+25.8% · S&P 500 +1.9%
EPS of $-129.10 missed the $-12.96 estimate on $0.00 revenue.
−3.2% · S&P 500 +0.8%
EPS of $-4.18 missed the $-4.08 estimate on $0.00 revenue.
−4.9% · S&P 500 +0.2%
Decoy Therapeutics shares rose 62.3%, while the S&P 500 rose 1.6%.
+62.3%, the year's best day · S&P 500 +1.6%
Building on the result, Decoy has opened an exploratory program to design D-MAVs against filoviruses, including Ebola and Marburg.
−25.8% · S&P 500 0.0%
EPS of $-4.46 missed the $-2.88 estimate on $227,629.00 revenue.
−5.0% · S&P 500 +0.7%
Decoy Therapeutics shares fell 25.2%, while the S&P 500 fell 0.7%.
−25.2% · S&P 500 −0.7%
Decoy Therapeutics closed at its lowest level of the year, 93.7% below where the year started.
−5.9% · S&P 500 +0.7%
Where it ended: a close of $1.05 on Nov 12, 2026.
Nothing in the past 12 months.
All DCOY dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DCOY and SPY from Benzinga historical bars. Not investment advice.
